Concepedia

Sam Hana

SH

7

Publications

171

Citations

7

H-Index

2017

Active since

Affiliations

Biogen (United States)(Current)

Chart Industries (United States)

University of Toronto

Sam Hana is an author at Biogen (United States) specializing in gene editing, genome editing, and medicine.

ORCID

Top concepts

Publications per year

2017–2024

7

Publications

7

Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice

Sam Hana, Michael Peterson, Helen McLaughlin et al. · Gene Therapy · 2021 · 43 citations · Full text

Cloning and Functional Characterization of Octβ2-Receptor and Tyr1-Receptor in the Chagas Disease Vector, Rhodnius prolixus

Sam Hana, Angela B. Lange · Frontiers in Physiology · 2017 · 32 citations · Full text

In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

Yi A. Chen, Mark W. Kankel, Sam Hana et al. · Gene Therapy · 2022 · 25 citations · Full text

, , +10

Octopamine and tyramine regulate the activity of reproductive visceral muscles in the adult female blood-feeding bug, <i>Rhodnius prolixus</i>

Sam Hana, Angela B. Lange · Journal of Experimental Biology · 2017 · 22 citations · Full text

Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice

Tess Torregrosa, Sydney Lehman, Sam Hana et al. · Gene Therapy · 2021 · 19 citations · Full text

, , +15

Rows per page

1–5 of 7